Adcock Ingram Holdings | AIP - Interest Expense On Debt



Adcock Ingram Holdings reported 2.65M in Interest Expense on Debt for its fiscal semester ending in June of 2024.


Interest Expense On Debt Change Date
Alaunos Therapeutics USD 0 0 Dec/2023
Aspen Pharmacare ZAR 631.5M 0 Jun/2024
Avita Medical AUD 1.35M 230K Jun/2024
Dianthus Therapeutics 4.44M 263K Sep/2024
Ionis Pharmaceuticals USD 19M 0 Jun/2025
IQVIA Holdings USD 182M 17M Jun/2025
Life Healthcare ZAR 167M 250M Jun/2023
Moderna USD 1000K 0 Jun/2025
Netcare ZAR 529M 57M Jun/2023
Organon & Co USD 131M 7M Jun/2025
Revvity USD 22.94M 27K Jun/2025
Tectonic Therapeutic USD 17K 5K Jun/2025
Viatris USD 116.6M 1.1M Jun/2025
Xeris Pharmaceuticals USD 7.36M 343K Jun/2025